Drawing for HALIXPEDITE

USPTO serial 79425486

HALIXPEDITE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
MORRIS, KRISTINA KLOIBER
Law office
TMO LAW OFFICE 116

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HALIXPEDITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations; biopharmaceutical products and preparations.ACTIVE
040Custom manufacture of pharmaceuticals and biopharmaceutical preparations; treatment of materials in the manufacture of pharmaceutical preparations and biopharmaceutical preparations, for others (provided by a contract manufacturing organization).ACTIVE
042Scientific and technological services of a pharmaceutical and biopharmaceutical company, including the development of manufacturing processes for pharmaceutical and biopharmaceutical preparations; pharmaceutical and biopharmaceutical research and development; scientific research regarding pharmaceutical and biopharmaceutical preparations; gene therapy research; scientific laboratory services and laboratory research relating to pharmaceutical and biopharmaceutical preparations.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 27, 2026MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 27, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 31, 2025RFNTREFUSAL PROCESSED BY IB
Oct 31, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 12, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 12, 2025RFRRREFUSAL PROCESSED BY MPU
Aug 27, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 13, 2025DOCKASSIGNED TO EXAMINER
Jun 6, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jun 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance